Literature DB >> 95789

The simultaneous observations of immunofluorescence and cellular morphology in viral infections: a new procedure.

K Takada1, T Aya, T Osato.   

Abstract

A simple method for comparative observations of immunofluorescence and cellular morphology has been developed in the investigation of Epstein-Barr virus (EBV) infection and oncogenesis. When cells were stained for immunofluorescence of EBV-determined nuclear antigen, early antigens, or the viral capsid antigen, followed by treatment with hematoxylin, viral marker expression and cellular morphology could be simultaneously observed in individual cells by simply changing ultraviolet illumination to visible light. In our double-staining method, hematoxylin was not counteractive to specific immunofluorescence, and pretreatment of cells with antibodies did not affect hematoxylin staining. This method may possibly be more widely applied in virology and other fields.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 95789     DOI: 10.1007/bf02125492

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  17 in total

1.  The development of Sendai virus in Earle's L cells as revealed by fluorescent antibody staining. Growth characteristics of myxoviruses in tissue culture. 4th.

Authors:  T OSATO; N ISHIDA
Journal:  Tohoku J Exp Med       Date:  1961-02-25       Impact factor: 1.848

2.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

3.  A simple viability test of cells producing viral antigen. Brief report.

Authors:  F Mizuno; T Osato
Journal:  Arch Gesamte Virusforsch       Date:  1973

4.  EB viral genomes in epithelial nasopharyngeal carcinoma cells.

Authors:  H Wolf; H zur Hausen; V Becker
Journal:  Nat New Biol       Date:  1973-08-22

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

7.  Density changes of cultured Burkitt lymphoma cells following EB viral synthesis.

Authors:  K Sugawara; F Mizuno; T Osato
Journal:  Nat New Biol       Date:  1971-09-22

8.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  1 in total

1.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.

Authors:  K Takada; T Osato
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.